Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

32.50 +1.16 (+3.70%)

Streaming Delayed Price Updated: 11:34 AM EDT, Mar 25, 2026 Add to My Watchlist

Price and Volume

Volume	429,611
Open	32.15
Bid (Size)	32.46 (200)
Ask (Size)	32.54 (200)
Prev. Close	31.34
Today's Range	31.73 - 33.45
52wk Range	30.11 - 90.32
Shares Outstanding	8,168,788
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

SLNO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Soleno Therapeutics (SLNO) Investors of Securities Class Action Deadline on May 5, 2026

Today 11:11 EDT

From Faruqi & Faruqi LLP

Via GlobeNewswire

SOLENO THERAPEUTICS Deadline to Lead in Securities Class Action Lawsuit is May 5, 2026 - Contact Kaplan Fox

Today 10:00 EDT

NEW YORK, NY - March 25, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Soleno Therapeutics, Inc. (“Soleno” or the “Company”) (NASDAQ:...

Via TheNewswire.com

Performance

YTD	-31.1%	-31.1%
1 Month	-18.1%	-18.1%
3 Month	-33.5%	-33.5%
6 Month	-42.8%	-42.8%
1 Year	-35.2%	-35.2%

More News

SOLENO THERAPEUTICS Deadline to Lead in Securities Class Action Lawsuit is May 5, 2026 - Contact Kaplan Fox

Today 10:00 EDT

Via NewMediaWire

Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

Today 8:23 EDT

From Grabar Law Office

Via GlobeNewswire

Soleno Therapeutics, Inc. Notice of May 5, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

March 24, 2026

From Kahn Swick & Foti, LLC

Via GlobeNewswire

Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) Seeking Recovery - Contact Kaplan Fox Before Deadline on May 5, 2026

March 24, 2026

Via NewMediaWire

Investors of Soleno Therapeutics, Inc. (NASDAQ: SLNO) Seeking Recovery - Contact Kaplan Fox Before Deadline on May 5, 2026

March 24, 2026

Via TheNewswire.com

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Soleno Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – SLNO

March 24, 2026

From Pomerantz LLP

Via GlobeNewswire

SLNO Investor Alert: Soleno Therapeutics, Inc. Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Commercial Viability Risks: Levi & Korsinsky

March 24, 2026

From Levi & Korsinsky, LLP

Via Business Wire

SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

March 24, 2026

From Schall Law

Via GlobeNewswire

Soleno Therapeutics, Inc. (SLNO) Securities Fraud Class Action Lawsuit Filed; May 5, 2026, Lead Plaintiff Deadline

March 24, 2026

Via TheNewswire.com

Soleno Therapeutics, Inc. (SLNO) Securities Fraud Class Action Lawsuit Filed; May 5, 2026, Lead Plaintiff Deadline

March 24, 2026

Via NewMediaWire

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Soleno Therapeutics, Inc. (SLNO)

March 24, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR); Molina Healthcare, Inc. (NYSE: MOH); and Soleno Therapeutics, Inc. (NASDAQ: SLNO): Grabar Law Office Investigates Claims on Your Behalf

March 23, 2026

From Grabar Law Office

Via GlobeNewswire

Soleno Therapeutics, Inc. (SLNO) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

March 22, 2026

Via TheNewswire.com

Soleno Therapeutics, Inc. (SLNO) Investors Have Opportunity to Lead Securities Fraud Class Action Lawsuit

March 22, 2026

Via NewMediaWire

Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit Seeks Recovery for Investors; May 5, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

March 21, 2026

Via NewMediaWire

Soleno Therapeutics, Inc. (SLNO) Class Action Lawsuit Seeks Recovery for Investors; May 5, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP

March 21, 2026

Via TheNewswire.com

SLNO SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Soleno Therapeutics, Inc. Investors - Contact Kirby McInerney LLP by May 5, 2026

March 20, 2026

From Kirby McInerney LLP

Via GlobeNewswire

March 20, 2026

From Grabar Law Office

Via GlobeNewswire

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SLNO

March 19, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm

March 19, 2026

Via TheNewswire.com

SLNO Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages SLNO Investors With Losses to Contact the Firm

March 19, 2026

Via NewMediaWire

SOLENO THERAPEUTICS, INC. (SLNO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Soleno Therapeutics, Inc. Investors of Upcoming Deadline

March 19, 2026

From Bernstein Liebhard LLP

Via GlobeNewswire

Soleno Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Soleno Therapeutics, Inc. - SLNO

March 18, 2026

From SkyMedia, LLC

Via GlobeNewswire

Frequently Asked Questions

Is Soleno Therapeutics, Inc. - Common Stock publicly traded?

Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?

Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?

The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market

What is the current price of Soleno Therapeutics, Inc. - Common Stock?

The current price of Soleno Therapeutics, Inc. - Common Stock is 32.50

When was Soleno Therapeutics, Inc. - Common Stock last traded?

The last trade of Soleno Therapeutics, Inc. - Common Stock was at 03/25/26 11:34 AM ET

What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?

The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 265.49M

How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?

Soleno Therapeutics, Inc. - Common Stock has 265M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.